Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Reality Status Judgments of Real and Fantastical Events in Children's Prefrontal Cortex: An fNIRS Study.

Li H, Liu T, Woolley JD, Zhang P.

Front Hum Neurosci. 2019 Dec 20;13:444. doi: 10.3389/fnhum.2019.00444. eCollection 2019.

2.

Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.

Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD.

Alcohol Clin Exp Res. 2019 Dec;43(12):2627-2636. doi: 10.1111/acer.14217. Epub 2019 Nov 6.

PMID:
31610033
3.

Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.

Abram SV, De Coster L, Roach BJ, Mueller BA, van Erp TGM, Calhoun VD, Preda A, Lim KO, Turner JA, Ford JM, Mathalon DH, Woolley JD.

Schizophr Bull. 2019 Oct 9. pii: sbz091. doi: 10.1093/schbul/sbz091. [Epub ahead of print]

PMID:
31595302
4.

Oxytocin increases eye gaze in schizophrenia.

Bradley ER, Seitz A, Niles AN, Rankin KP, Mathalon DH, O'Donovan A, Woolley JD.

Schizophr Res. 2019 Oct;212:177-185. doi: 10.1016/j.schres.2019.07.039. Epub 2019 Aug 12.

PMID:
31416746
5.

Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial.

De Coster L, Lin L, Mathalon DH, Woolley JD.

Neuropsychopharmacology. 2019 Oct;44(11):1925-1931. doi: 10.1038/s41386-019-0417-5. Epub 2019 May 18.

PMID:
31103018
6.

Psychedelic-Assisted Group Therapy: A Systematic Review.

Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD.

J Psychoactive Drugs. 2019 Apr-Jun;51(2):174-188. doi: 10.1080/02791072.2019.1593559. Epub 2019 Apr 5.

PMID:
30950777
7.

Victory is its own reward: oxytocin increases costly competitive behavior in schizophrenia.

Bradley ER, Brustkern J, De Coster L, van den Bos W, McClure SM, Seitz A, Woolley JD.

Psychol Med. 2019 Apr 4:1-9. doi: 10.1017/S0033291719000552. [Epub ahead of print]

PMID:
30944045
8.

Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity.

Marton T, Barnes DE, Wallace A, Woolley JD.

Biol Psychiatry. 2019 Jun 15;85(12):e75-e76. doi: 10.1016/j.biopsych.2019.02.008. Epub 2019 Mar 27. No abstract available.

PMID:
30926131
9.

Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.

Stauffer CS, Moschetto JM, McKernan SM, Hsiang E, Borsari B, Woolley JD.

Trials. 2019 Feb 21;20(1):145. doi: 10.1186/s13063-019-3225-7.

10.

Oxytocin does not improve working memory in schizophrenia.

Bradley ER, van Nieuwenhuizen A, Abram S, Niles AN, Woolley JD.

Schizophr Res. 2019 Jun;208:486-487. doi: 10.1016/j.schres.2019.01.020. Epub 2019 Feb 1. No abstract available.

PMID:
30712813
11.

Effects of oxytocin administration on receiving help.

Human LJ, Woolley JD, Mendes WB.

Emotion. 2018 Oct;18(7):980-988. doi: 10.1037/emo0000369. Epub 2017 Nov 27.

PMID:
29172621
12.

Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.

Bürkner PC, Williams DR, Simmons TC, Woolley JD.

Schizophr Bull. 2017 Oct 21;43(6):1291-1303. doi: 10.1093/schbul/sbx053.

13.

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Bradley ER, Woolley JD.

Neurosci Biobehav Rev. 2017 Sep;80:36-56. doi: 10.1016/j.neubiorev.2017.05.007. Epub 2017 May 12. Review.

14.

Combining oxytocin administration and positive emotion inductions: Examining social perception and analytical performance.

Human LJ, Thorson KR, Woolley JD, Mendes WB.

Horm Behav. 2017 Apr;90:120-128. doi: 10.1016/j.yhbeh.2017.03.002. Epub 2017 Mar 21.

PMID:
28324706
15.

Interactions Between Knowledge and Testimony in Children's Reality-Status Judgments.

Lopez-Mobilia G, Woolley JD.

J Cogn Dev. 2016;17(3):486-504. doi: 10.1080/15248372.2015.1061529. Epub 2016 Jan 11.

16.

Wondering how: Children's and adults' explanations for mundane, improbable, and extraordinary events.

Woolley JD, Cornelius CA.

Psychon Bull Rev. 2017 Oct;24(5):1586-1596. doi: 10.3758/s13423-016-1127-1.

PMID:
28176289
17.

Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.

Woolley JD, Chuang B, Fussell C, Scherer S, Biagianti B, Fulford D, Mathalon DH, Vinogradov S.

Psychol Med. 2017 May;47(7):1311-1322. doi: 10.1017/S0033291716003433. Epub 2017 Jan 16.

18.

American Alcohol Photo Stimuli (AAPS): A standardized set of alcohol and matched non-alcohol images.

Stauffer CS, Dobberteen L, Woolley JD.

Am J Drug Alcohol Abuse. 2017 Nov;43(6):647-655. doi: 10.1080/00952990.2016.1253093. Epub 2016 Nov 28.

PMID:
27893279
19.

Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder.

Mitchell JM, Arcuni PA, Weinstein D, Woolley JD.

J Addict Med. 2016 May-Jun;10(3):182-9. doi: 10.1097/ADM.0000000000000213.

PMID:
27159342
20.

The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.

Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S.

Psychopharmacology (Berl). 2016 Jul;233(13):2571-80. doi: 10.1007/s00213-016-4308-8. Epub 2016 May 3.

PMID:
27137199
21.

A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD.

Addict Res Theory. 2016;24(6):490-498. doi: 10.3109/16066359.2016.1173682. Epub 2016 May 25.

22.

Intranasal Oxytocin Mechanisms Can Be Better Understood, but Its Effects on Social Cognition and Behavior Are Not to Be Sniffed At.

Quintana DS, Woolley JD.

Biol Psychiatry. 2016 Apr 15;79(8):e49-50. doi: 10.1016/j.biopsych.2015.06.021. Epub 2015 Jul 2. No abstract available.

PMID:
26212900
23.

The development of children's concepts of invisibility.

Woolley JD, McInnis MA.

Cogn Dev. 2015 Apr-Jun;34:63-75.

24.

Impaired Recognition and Regulation of Disgust Is Associated with Distinct but Partially Overlapping Patterns of Decreased Gray Matter Volume in the Ventroanterior Insula.

Woolley JD, Strobl EV, Sturm VE, Shany-Ur T, Poorzand P, Grossman S, Nguyen L, Eckart JA, Levenson RW, Seeley WW, Miller BL, Rankin KP.

Biol Psychiatry. 2015 Oct 1;78(7):505-14. doi: 10.1016/j.biopsych.2014.12.031. Epub 2015 Feb 7.

25.

Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.

Woolley JD, Lam O, Chuang B, Ford JM, Mathalon DH, Vinogradov S.

Psychoneuroendocrinology. 2015 Mar;53:217-22. doi: 10.1016/j.psyneuen.2014.12.018. Epub 2015 Jan 7.

26.

Can we bottle psychosocial treatments for addiction? The role of oxytocin.

Stauffer CS, Woolley JD.

J Clin Psychiatry. 2014 Sep;75(9):1028-9. doi: 10.4088/JCP.14ac09437. No abstract available.

PMID:
25295428
27.

What do mind readers know and what do we know about mind readers?

Woolley JD.

Br J Dev Psychol. 2014 Nov;32(4):388-90. doi: 10.1111/bjdp.12058. Epub 2014 Aug 22.

PMID:
25145941
28.

Oxytocin administration enhances controlled social cognition in patients with schizophrenia.

Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S.

Psychoneuroendocrinology. 2014 Sep;47:116-25. doi: 10.1016/j.psyneuen.2014.04.024. Epub 2014 May 27. Erratum in: Psychoneuroendocrinology. 2015 Feb;52:13.

29.

Satiety-related hormonal dysregulation in behavioral variant frontotemporal dementia.

Woolley JD, Khan BK, Natesan A, Karydas A, Dallman M, Havel P, Miller BL, Rankin KP.

Neurology. 2014 Feb 11;82(6):512-20. doi: 10.1212/WNL.0000000000000106. Epub 2014 Jan 10.

30.

Revisiting the fantasy-reality distinction: children as naïve skeptics.

Woolley JD, E Ghossainy M.

Child Dev. 2013 Sep-Oct;84(5):1496-510. doi: 10.1111/cdev.12081. Epub 2013 Mar 15. Review.

31.

Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman.

Khan BK, Woolley JD, Chao S, See T, Karydas AM, Miller BL, Rankin KP.

Psychosomatics. 2012 May-Jun;53(3):280-4. doi: 10.1016/j.psym.2011.04.005. Epub 2012 Jan 28. No abstract available.

32.

Development of the use of conversational cues to assess reality status.

Woolley JD, Ma L, Lopez-Mobilia G.

J Cogn Dev. 2011 Jan 1;12(4):537-555.

33.

BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease.

Woolley JD, Strobl EV, Shelly WB, Karydas AM, Robin Ketelle RN, Wolkowitz OM, Miller BL, Rankin KP.

Curr Alzheimer Res. 2012 Sep;9(7):815-21.

34.

Does God make it real? Children's belief in religious stories from the Judeo-Christian tradition.

Vaden VC, Woolley JD.

Child Dev. 2011 Jul-Aug;82(4):1120-35. doi: 10.1111/j.1467-8624.2011.01589.x. Epub 2011 Apr 5.

35.
36.
37.

The development of children's ability to use evidence to infer reality status.

Tullos A, Woolley JD.

Child Dev. 2009 Jan-Feb;80(1):101-14. doi: 10.1111/j.1467-8624.2008.01248.x.

38.

Frontotemporal dementia and mania.

Woolley JD, Wilson MR, Hung E, Gorno-Tempini ML, Miller BL, Shim J.

Am J Psychiatry. 2007 Dec;164(12):1811-6. No abstract available.

PMID:
18056235
39.

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia.

Woolley JD, Gorno-Tempini ML, Seeley WW, Rankin K, Lee SS, Matthews BR, Miller BL.

Neurology. 2007 Oct 2;69(14):1424-33.

PMID:
17909155
40.

Development of beliefs about storybook reality.

Woolley JD, Cox V.

Dev Sci. 2007 Sep;10(5):681-93.

PMID:
17683351
41.

Opposing effects of intra-nucleus accumbens mu and kappa opioid agonists on sensory specific satiety.

Woolley JD, Lee BS, Kim B, Fields HL.

Neuroscience. 2007 Jun 8;146(4):1445-52. Epub 2007 Apr 19.

PMID:
17445988
42.

Nucleus accumbens opioid signaling conditions short-term flavor preferences.

Woolley JD, Lee BS, Taha SA, Fields HL.

Neuroscience. 2007 Apr 25;146(1):19-30. Epub 2007 Feb 21.

PMID:
17320293
43.

Effects of context on judgments concerning the reality status of novel entities.

Woolley JD, Van Reet J.

Child Dev. 2006 Nov-Dec;77(6):1778-93.

PMID:
17107460
44.

Verbal-behavioral dissociations in development.

Woolley JD.

Child Dev. 2006 Nov-Dec;77(6):1539-53.

PMID:
17107443
45.

Nucleus accumbens opioids regulate flavor-based preferences in food consumption.

Woolley JD, Lee BS, Fields HL.

Neuroscience. 2006 Nov 17;143(1):309-17.

PMID:
17049180
46.

Endogenous opioids encode relative taste preference.

Taha SA, Norsted E, Lee LS, Lang PD, Lee BS, Woolley JD, Fields HL.

Eur J Neurosci. 2006 Aug;24(4):1220-6. Epub 2006 Aug 21.

PMID:
16925586
47.

The autonomic and behavioral profile of emotional dysregulation.

Woolley JD, Gorno-Tempini ML, Werner K, Rankin KP, Ekman P, Levenson RW, Miller BL.

Neurology. 2004 Nov 9;63(9):1740-3.

PMID:
15534273
48.

Cognitive and behavioral profile in a case of right anterior temporal lobe neurodegeneration.

Gorno-Tempini ML, Rankin KP, Woolley JD, Rosen HJ, Phengrasamy L, Miller BL.

Cortex. 2004 Sep-Dec;40(4-5):631-44.

PMID:
15505973
49.

A visit from the Candy Witch: factors influencing young children's belief in a novel fantastical being.

Woolley JD, Boerger EA, Markman AB.

Dev Sci. 2004 Sep;7(4):456-68.

PMID:
15484594
50.

Buccofacial apraxia and the expression of emotion.

Woolley JD.

Ann N Y Acad Sci. 2003 Dec;1000:395-401. No abstract available.

PMID:
14766655

Supplemental Content

Loading ...
Support Center